Send the following on WhatsApp
Continue to Chat2022 上半年財報可觀,AZ 自臨床試驗名單剔除兩項 mRNA 候選藥物 https://geneonline.news/az-clinical-trials-list-mrna-candidate-drug/
2022 上半年財報可觀,AZ 自臨床試驗名單剔除兩項 mRNA 候選藥物 https://geneonline.news/az-clinical-trials-list-mrna-candidate-drug/